SPOTLIGHT -
EP. 1: Introduction: Multidisciplinary Frontline Treatment of mRCC
EP. 2: Treatment of Metastatic Non-Clear Cell RCC
EP. 3: Frontline Treatment of Poor-Risk mRCC
EP. 4: Cytoreductive Nephrectomy in Untreated Metastatic RCC
EP. 5: Optimizing the Upfront Treatment of mRCC
EP. 6: Second-Line Treatment of Metastatic Renal Cell Carcinoma
EP. 7: Second-Line Angiogenesis Inhibition in mRCC
EP. 8: Case Study: Treating Progressive Renal Cell Carcinoma
EP. 9: Case Study: Observation in Metastatic RCC
EP. 10: Drug Holidays in Renal Cell Carcinoma
EP. 11: Case Study: Utilizing Multiple Therapies in mRCC
EP. 12: Evolving Role of Genomic Testing in RCC
EP. 13: Novel Therapies in Renal Cell Carcinoma
EP. 14: RCC Journal Highlights and Implications for Clinical Practice
EP. 15: Conclusion: Optimizing the Treatment of RCC
Further Understanding of Immune Mechanisms in Tumor Microenvironment Is Key to Advancing Immunotherapy in Solid Tumors
Navigating Systemic Therapy for RCC: Balancing Risk Status and Response
ADCs, Novel Targets Represent Next Wave of Treatment Advances in mCRPC
Precision Medicine in Prostate Cancer Care: Keeping Up With Evolving Guidance for Testing and Decision Making
